Five out of 6 patients with a PIK3CA mutation in either primary tumor or relapse tissues exhibited one of the 3 “Hotspot” mutations shown to cause gains in protein enzymatic function and induce oncogenic transformation (E542 and E545 in the helical domain and H1047 in the kinase domain) [19, 20]. This evidence concerns the gene PIK3CA and neoplasm.